-
Policy, Patients & Progress
Prioritizing the Needs of Children With CancerAACR Pediatric Cancer Progress Report 2025 highlights treatment advances and prompts policymakers to keep the momentum going.
by David Zahavi, PhD
-
Get Involved
Cushions of ComfortAva Clay sews pillows that help ease pain experienced by people with a chemotherapy port.
by Thomas Celona
-
Policy, Patients & Progress
Rallying in a Year of UncertaintyAt a defining moment, a broad coalition came to Capitol Hill to protect science, defend progress and stand up for patients. Congress must hear from you next.
by Carly McCallie
-
Get Involved
Making Moments CountThe Zoefia Alexandria Foundation supplies toys and activities to pediatric cancer patients to allow for joy during treatment.
by Thomas Celona
-
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona
-
Policy Matters
The Future of Cancer Research Rests With CongressFederal funding will determine whether lifesaving science continues to reach patients.
by Carly McCallie
-
Redefining Cancer SurvivorshipAs people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
by Thomas Celona
-
Family of Henrietta Lacks Works for ‘Health Intelligence’Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
-
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Policy Matters
Toward Improved Dosing in the Precision Oncology EraA forthcoming article series outlines considerations for the dose optimization of modern oncology drugs.
by Brad Davidson, PhD
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
